References
Nanocan’s inaugural innovation derives from its worldwide exclusive license for Immunogenic Smart Radiotherapy Biomaterial (iSRB)
technology. Read about the licensing of its iSRB technology here.
Publications on the iSRB technology are listed below:
Physics in Medicine and Biology
Published August 26, 2015
International Journal of Radiation Oncology, Biology, Physics
Published November 1, 2016
Physics in Medicine and Biology
Published December 2, 2016
British Journal of Radiology
Published June 6, 2017
Frontiers in Oncology
Published September 19, 2017
Nature Reviews Cancer
Published February 16, 2018
Frontiers in Oncology
Published March 12, 2018
Frontiers in Oncology
Published April 24, 2018